Keryx Biopharmaceuticals
Clinical trials sponsored by Keryx Biopharmaceuticals, explained in plain language.
-
New iron pill trial for kids with kidney disease falls through
Disease control TerminatedThis study aimed to test the safety of a medicine called ferric citrate in children aged 6 to 17 with iron deficiency anemia and chronic kidney disease (not on dialysis). The trial was planned to last 24 weeks and compare two treatment approaches. However, the study was withdrawn…
Phase: PHASE3 • Sponsor: Keryx Biopharmaceuticals • Aim: Disease control
Last updated May 17, 2026 14:57 UTC
-
Kidney Kids' phosphorus drug trial halted midway
Disease control TerminatedThis study tested the safety of ferric citrate in 45 children (ages 6-17) with chronic kidney disease and high phosphorus levels. The medicine aims to control phosphorus, a common problem in kidney disease. The trial was suspended, so results are not yet available.
Phase: PHASE3 • Sponsor: Keryx Biopharmaceuticals • Aim: Disease control
Last updated May 17, 2026 14:57 UTC